Europe - Euronext Paris - EPA:BIM - FR0013280286 - Common Stock
Taking everything into account, BIM scores 6 out of 10 in our fundamental rating. BIM was compared to 62 industry peers in the Health Care Equipment & Supplies industry. BIM is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. BIM has a decent growth rate and is not valued too expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.04% | ||
| ROE | 9.61% | ||
| ROIC | 8.55% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.37% | ||
| PM (TTM) | 9.17% | ||
| GM | 56.27% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 1.15 | ||
| Altman-Z | 6.87 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.27 | ||
| Quick Ratio | 1.3 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.58 | ||
| Fwd PE | 21.77 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 29.74 | ||
| EV/EBITDA | 13.36 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.82% |
EPA:BIM (12/31/2025, 7:00:00 PM)
110.3
+0.2 (+0.18%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.82% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.58 | ||
| Fwd PE | 21.77 | ||
| P/S | 3.17 | ||
| P/FCF | 29.74 | ||
| P/OCF | 16.57 | ||
| P/B | 3.32 | ||
| P/tB | 4.67 | ||
| EV/EBITDA | 13.36 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.04% | ||
| ROE | 9.61% | ||
| ROCE | 11.69% | ||
| ROIC | 8.55% | ||
| ROICexc | 9.37% | ||
| ROICexgc | 13.09% | ||
| OM | 12.37% | ||
| PM (TTM) | 9.17% | ||
| GM | 56.27% | ||
| FCFM | 10.65% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 1.15 | ||
| Debt/EBITDA | 0.36 | ||
| Cap/Depr | 73.47% | ||
| Cap/Sales | 8.47% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 80% | ||
| Profit Quality | 116.14% | ||
| Current Ratio | 2.27 | ||
| Quick Ratio | 1.3 | ||
| Altman-Z | 6.87 |
ChartMill assigns a fundamental rating of 6 / 10 to BIM.PA.
ChartMill assigns a valuation rating of 4 / 10 to BIOMERIEUX (BIM.PA). This can be considered as Fairly Valued.
BIOMERIEUX (BIM.PA) has a profitability rating of 6 / 10.
The financial health rating of BIOMERIEUX (BIM.PA) is 8 / 10.
The dividend rating of BIOMERIEUX (BIM.PA) is 3 / 10 and the dividend payout ratio is 28.04%.